Shopping Cart 0
Cart Subtotal
USD 0

SalvaRx Group Plc (SALV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipeline which anti-cancer treatments based on iNKT cells under license from the Ludwig Institute for cancer research. The company offers acquisition of immune-oncology therapeutics which complementary to anti-PD1 or anti-PDL1 therapies. It operates in Northern Poland and the UK. SalvaRx is headquartered in Ramsey, the UK.

SalvaRx Group Plc (SALV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SalvaRx Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Intensity Therapeutics Raises USD10 Million in Financing 10

Intensity Therapeutics Raises USD2 Million in Series A Financing 11

SalvaRx Raises USD0.3 Million in Financing Round 12

Iox Therapeutics Raises Funds through Financing Round 13

Partnerships 14

SalvaRx Forms Joint Venture with Immunova 14

SalvaRx to Enter into Agreement with D5 Pharma 15

Licensing Agreements 16

iOx Therapeutics Enters into Licensing Agreement with Ludwig Institute 16

Equity Offering 17

SalvaRx Raises Funds through Private Placement of Shares up on Exercise of Warrants 17

Rift Biotherapeutics to Raise USD1 Million in Private Placement of Shares 18

Debt Offering 19

Portage Biotech Invests USD1 Million in iOx Therapeutics 19

Acquisition 20

Portage Biotech to Acquire SalvaRx for USD71.7 Million 20

3Legs Resources Acquires Remaining 88.9% Stake in SalvaRx in Reverse Takeover Transaction 22

SalvaRx Acquires 60.49% Stake in iOX Therapeutics 23

SalvaRx Group Plc-Key Competitors 24

SalvaRx Group Plc-Key Employees 25

SalvaRx Group Plc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Sep 27, 2018: SalvaRx Group: Half Yearly Report to 30 June 2018 27

Jun 30, 2017: SalvaRx Group: Final Results 29

Other Significant Developments 30

Mar 08, 2018: SalvaRx: business update of March 2018 30

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SalvaRx Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SalvaRx Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8

SalvaRx Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Intensity Therapeutics Raises USD10 Million in Financing 10

Intensity Therapeutics Raises USD2 Million in Series A Financing 11

SalvaRx Raises USD0.3 Million in Financing Round 12

Iox Therapeutics Raises Funds through Financing Round 13

SalvaRx Forms Joint Venture with Immunova 14

SalvaRx to Enter into Agreement with D5 Pharma 15

iOx Therapeutics Enters into Licensing Agreement with Ludwig Institute 16

SalvaRx Raises Funds through Private Placement of Shares up on Exercise of Warrants 17

Rift Biotherapeutics to Raise USD1 Million in Private Placement of Shares 18

Portage Biotech Invests USD1 Million in iOx Therapeutics 19

Portage Biotech to Acquire SalvaRx for USD71.7 Million 20

3Legs Resources Acquires Remaining 88.9% Stake in SalvaRx in Reverse Takeover Transaction 22

SalvaRx Acquires 60.49% Stake in iOX Therapeutics 23

SalvaRx Group Plc, Key Competitors 24

SalvaRx Group Plc, Key Employees 25

SalvaRx Group Plc, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

SalvaRx Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.